Curaleaf (OTCMKTS:CURLF) Releases Earnings Results, Beats Estimates By $0.17 EPS

Curaleaf (OTCMKTS:CURLF) issued its earnings results on Tuesday. The company reported $0.09 EPS for the quarter, topping the consensus estimate of ($0.08) by $0.17, Zacks reports. Curaleaf had a negative return on equity of 23.17% and a negative net margin of 18.08%.The firm had revenue of $324.23 million during the quarter, compared to analysts’ expectations of $316.62 million.

Curaleaf Price Performance

Shares of Curaleaf stock opened at $3.48 on Wednesday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.76 and a current ratio of 1.52. The firm’s 50-day simple moving average is $2.52 and its 200-day simple moving average is $2.59. Curaleaf has a twelve month low of $0.72 and a twelve month high of $5.05. The firm has a market cap of $2.39 billion, a P/E ratio of -11.60 and a beta of 1.58.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.